| Manager | Titel | Alter | Seit |
|---|---|---|---|
Thomas Loewald
CEO | Vorstandsvorsitzender | 63 | 07.09.2020 |
Robert Green
DFI | Finanzdirektor/CFO | 54 | 01.01.2020 |
Matthew Bio
CTO | Technik-/Wissenschafts-/F&E-Leiter | - | 01.01.2023 |
| Verwaltungsratsmitglied | Titel | Alter | Seit |
|---|---|---|---|
Wayne Hewett
CHM | Vorsitzender | 61 | 01.12.2019 |
| % | % 5 Tage | % 1 Jahr | Veränd. 3 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.08% | - | - | 2.02 Mrd. | ||
| +0.92% | +0.47% | +43.59% | +143.50% | 996 Mrd. | ||
| +0.80% | +2.90% | +58.35% | +45.64% | 580 Mrd. | ||
| +0.06% | +6.17% | +26.59% | +72.81% | 415 Mrd. | ||
| +4.27% | -2.44% | +22.01% | +15.66% | 326 Mrd. | ||
| +0.27% | +5.52% | +31.12% | +40.08% | 280 Mrd. | ||
| +0.61% | +6.31% | +36.46% | +23.84% | 284 Mrd. | ||
| +1.18% | +12.42% | -27.65% | -41.41% | 210 Mrd. | ||
| +1.27% | +2.86% | +26.65% | +54.74% | 190 Mrd. | ||
| +0.09% | -0.23% | +16.75% | +61.56% | 155 Mrd. | ||
| Durchschnitt | +0.49% | +2.68% | +25.99% | +46.27% | 381.86 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.46% | +2.18% | +33.88% | +68.10% |
Beschäftigte
-
Sektor
Pharmazeutika
















